Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.
Authors: Chen, Charles D.1,2 (AUTHOR), McCullough, Austin1 (AUTHOR), Gordon, Brian1 (AUTHOR), Joseph-Mathurin, Nelly1 (AUTHOR), Flores, Shaney1 (AUTHOR), McKay, Nicole S.1 (AUTHOR), Hobbs, Diana A.1 (AUTHOR), Hornbeck, Russ1 (AUTHOR), Fagan, Anne M.3 (AUTHOR), Cruchaga, Carlos4 (AUTHOR), Goate, Alison M.5 (AUTHOR), Perrin, Richard J.3,6 (AUTHOR), Wang, Guoqiao7 (AUTHOR), Li, Yan3 (AUTHOR), Shi, Xinyu3 (AUTHOR), Xiong, Chengjie7 (AUTHOR), Pontecorvo, Michael J.8,9 (AUTHOR), Klein, Gregory10 (AUTHOR), Su, Yi11,12 (AUTHOR), Klunk, William E.13 (AUTHOR)
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 9, p2669-2682. 14p. 3 Color Photographs, 5 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-023-06209-0